GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » PuriBlood Medical Co Ltd (ROCO:6847) » Definitions » Net Current Asset Value

PuriBlood Medical Co (ROCO:6847) Net Current Asset Value : NT$4.94 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is PuriBlood Medical Co Net Current Asset Value?

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

PuriBlood Medical Co's net current asset value per share for the quarter that ended in Dec. 2023 was NT$4.94.

The historical rank and industry rank for PuriBlood Medical Co's Net Current Asset Value or its related term are showing as below:

ROCO:6847' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 16.94   Med: 18.73   Max: 22.77
Current: 22.37

During the past 6 years, the highest Price-to-Net-Current-Asset-Value Ratio of PuriBlood Medical Co was 22.77. The lowest was 16.94. And the median was 18.73.

ROCO:6847's Price-to-Net-Current-Asset-Value is ranked worse than
94.07% of 118 companies
in the Medical Diagnostics & Research industry
Industry Median: 4.315 vs ROCO:6847: 22.37

PuriBlood Medical Co Net Current Asset Value Historical Data

The historical data trend for PuriBlood Medical Co's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PuriBlood Medical Co Net Current Asset Value Chart

PuriBlood Medical Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Current Asset Value
Get a 7-Day Free Trial -4.42 5.28 8.81 8.00 4.94

PuriBlood Medical Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.81 7.99 8.00 7.02 4.94

Competitive Comparison of PuriBlood Medical Co's Net Current Asset Value

For the Diagnostics & Research subindustry, PuriBlood Medical Co's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PuriBlood Medical Co's Price-to-Net-Current-Asset-Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, PuriBlood Medical Co's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where PuriBlood Medical Co's Price-to-Net-Current-Asset-Value falls into.



PuriBlood Medical Co Net Current Asset Value Calculation

PuriBlood Medical Co's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Dec. 2023 is calculated as

Net Current Asset Value Per Share(A: Dec. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(154.655-84.351-0-0)/14.23
=4.94

PuriBlood Medical Co's Net Current Asset Value (NCAV) per share for the quarter that ended in Dec. 2023 is calculated as

Net Current Asset Value Per Share(Q: Dec. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(154.655-84.351-0-0)/14.23
=4.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PuriBlood Medical Co  (ROCO:6847) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


PuriBlood Medical Co Net Current Asset Value Related Terms

Thank you for viewing the detailed overview of PuriBlood Medical Co's Net Current Asset Value provided by GuruFocus.com. Please click on the following links to see related term pages.


PuriBlood Medical Co (ROCO:6847) Business Description

Traded in Other Exchanges
N/A
Address
Gongye E. 9th Road, Baoshan Township, 2nd Floor, No.11, Hsinchu County, Baoshan, TWN
PuriBlood Medical Co Ltd is engaged in developing solutions for leukoreduction, cell separation, and anti-fouling materials. Its technology provides protection to support living beings from medical devices to daily protection. The products of the company include Leukoreduction, Cell Seperation, and P-tex.

PuriBlood Medical Co (ROCO:6847) Headlines

No Headlines